Pfizer

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Pfizer 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About PFE

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. 

CEO
Albert Bourla
CEOAlbert Bourla
Employees
75,000
Employees75,000
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
1849
Founded1849
Employees
75,000
Employees75,000

PFE Key Statistics

Market cap
137.19B
Market cap137.19B
Price-Earnings ratio
18.19
Price-Earnings ratio18.19
Dividend yield
7.25%
Dividend yield7.25%
Average volume
58.67M
Average volume58.67M
High today
$24.35
High today$24.35
Low today
$23.87
Low today$23.87
Open price
$24.06
Open price$24.06
Volume
44.05M
Volume44.05M
52 Week high
$28.75
52 Week high$28.75
52 Week low
$23.11
52 Week low$23.11

Stock Snapshot

With a market cap of 137.19B, Pfizer(PFE) trades at $24.05. The stock has a price-to-earnings ratio of 18.19 and currently yields dividends of 7.25%.

During the trading session on 2026-07-07, Pfizer(PFE) shares reached a daily high of $24.35 and a low of $23.87. At a current price of $24.05, the stock is +0.8% higher than the low and still -1.2% under the high.

Trading volume for Pfizer(PFE) stock has reached 44.05M, versus its average volume of 58.67M.

The stock's 52-week range extends from a low of $23.11 to a high of $28.75.

The stock's 52-week range extends from a low of $23.11 to a high of $28.75.

PFE News

Barron's 4h
Former Pfizer Building Is Crumbling—Just as the Stock Has

Biotech and Pharma Former Pfizer Building Is Crumbling—Just as the Stock Has In this article PFE SPX LLY BNTX Workers at the former Pfizer headquarters were eva...

Former Pfizer Building Is Crumbling—Just as the Stock Has
TipRanks 7h
Pfizer Stock Bounces Back After an Analyst Downgrade

Pfizer (PFE) stock was recovering on Tuesday after a top Wall Street analyst hit the pharmaceutical company’s shares with a downgrade. Four-star HSBC analyst Ra...

The Motley Fool 7h
Opinion: Pfizer's Dividend Is Riskier Than You Might Think

It's hard not to love high dividend yields. Who doesn't want more dividends for their money? Pfizer (PFE +1.62%) and its current yield of 7% will certainly grab...

Opinion: Pfizer's Dividend Is Riskier Than You Might Think

Analyst ratings

62%

of 29 ratings
Buy
31%
Hold
62.1%
Sell
6.9%

More PFE News

Simply Wall St 7h
The Bull Case For Pfizer Could Change Following First CDK4/6 Maintenance Approval In HER2-Positive Breast Cancer

On June 24, 2026, Pfizer announced that the FDA approved IBRANCE (palbociclib) in combination with trastuzumab, with or without pertuzumab, and endocrine therap...

The Bull Case For Pfizer Could Change Following First CDK4/6 Maintenance Approval In HER2-Positive Breast Cancer
Nasdaq 10h
Pfizer or AstraZeneca: Which Stock Offers Better Long-Term Potential?

Pfizer PFE and AstraZeneca AZN are global pharmaceutical leaders with a strong presence in oncology. For Pfizer, oncology is a major growth driver, contributing...

Pfizer or AstraZeneca: Which Stock Offers Better Long-Term Potential?
Nasdaq 1d
Meet the 4 S&P 500 Dividend Stocks That Yield at Least 6%. Here's My Strongest Buy of the Bunch in July.

Key Points There are four non-REITs in the S&P 500 with dividend yields of more than 6%. The four stocks are Verizon, General Mills, Pfizer, and Kraft Heinz....

Meet the 4 S&P 500 Dividend Stocks That Yield at Least 6%. Here's My Strongest Buy of the Bunch in July.
TipRanks 2d
Pfizer downgraded to Hold from Buy at HSBC

HSBC downgraded Pfizer (PFE) to Hold from Buy with a price target of $28, down from $32. The firm lowered its view of the probability to market of sigvotatug ve...

Simply Wall St 5d
Pfizer Stock And 2 AI Healthcare Picks Investors May Want To Watch

Artificial intelligence in healthcare sits at the crossroads of two forces investors are watching closely today: inflation sensitive policy shifts and fast movi...

Pfizer Stock And 2 AI Healthcare Picks Investors May Want To Watch
Nasdaq 5d
Pfizer's CEO Says His Company Has a "Very Big Balance Sheet" to Do Deals. Here's the Perfect Next Acquisition Target for the Pharma Giant

Key Points Pfizer has the funds to acquire more companies. Buying Kailera Therapeutics would help Pfizer establish a stronger foothold in the weight-loss mark...

Pfizer's CEO Says His Company Has a "Very Big Balance Sheet" to Do Deals. Here's the Perfect Next Acquisition Target for the Pharma Giant
Simply Wall St 6d
Pfizer Stock May Be Fairly Priced On Its 22% Slide

Pfizer stock is coming off a difficult five-year stretch, with shareholders facing a material decline. The current valuation checks suggest the shares may now b...

Pfizer Stock May Be Fairly Priced On Its 22% Slide

People also own

Based on the portfolios of people who own PFE. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.